Clinical Trial Update: A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates Xeloda (capecitabine) in combination with chemotherapy for advanced/metastatic gastric cancer; the study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-19